The National Institute of Technology (NIT) Rourkela has introduced a revolutionary bioink made from natural materials for 3D bioprinting of bone tissues.
This innovation is a step forward in addressing the challenges associated with traditional bone repair techniques like grafting and implants.
Developed under the leadership of Prof. Devendra Verma, the bioink comprises chitosan, gelatin, and nanohydroxyapatite—all biocompatible materials that mimic the composition of natural bone. The unique formula allows the bioink to transition from liquid to gel when exposed to body temperature and pH, enabling direct application to injuries.
This innovation stands out for its ability to support bone regeneration, making it particularly suitable for reconstructive surgeries for the face and skull. The technology has received a patent (Patent No. 562791) and is undergoing further testing to ensure its readiness for clinical applications. The team plans to scale production via their startup, Quixotix Bioprinting Pvt. Ltd., with an aim to revolutionize regenerative medicine.
